| Product NDC: | 10544-082 | 
| Proprietary Name: | Cephalexin | 
| Non Proprietary Name: | Cephalexin | 
| Active Ingredient(s): | 500 mg/1 & nbsp; Cephalexin | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | CAPSULE | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 10544-082 | 
| Labeler Name: | Blenheim Pharmacal, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA062713 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20120801 | 
| Package NDC: | 10544-082-28 | 
| Package Description: | 28 CAPSULE in 1 BOTTLE (10544-082-28) | 
| NDC Code | 10544-082-28 | 
| Proprietary Name | Cephalexin | 
| Package Description | 28 CAPSULE in 1 BOTTLE (10544-082-28) | 
| Product NDC | 10544-082 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Cephalexin | 
| Dosage Form Name | CAPSULE | 
| Route Name | ORAL | 
| Start Marketing Date | 20120801 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Blenheim Pharmacal, Inc. | 
| Substance Name | CEPHALEXIN | 
| Strength Number | 500 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |